The Burgess Group Selects Concert Genetics to Power Genetic Test Claims Payment Automation
News provided by
Share this article
Share this article
ALEXANDRIA, Va. and NASHVILLE, Tenn., Dec. 15, 2020 /PRNewswire/ The Burgess Group ( Burgess ), a HealthEdge company, an innovative payment integrity software company focused on improving healthcare payment operations through technology, has selected Concert Genetics to deliver genetic testing claim edits within the Burgess Source® claims payment automation and business intelligence platform.
The solution integrates Concert s real-time claim editing capabilities, powered by patented machine learning capabilities, into Burgess Source, which enables complete claims payment automation through up-to-date regulatory content, claims pricing and editing, and real-time analytics tools.